The effect of sodium salicylate and aspirin on NF-kappa B.
B
B
Frantz
E A
EA
O'Neill
D001241:Aspirin / Q000494:pharmacology*; D006801:Humans; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011401:Promoter Regions, Genetic / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D012980:Sodium Salicylate / Q000494:pharmacology*; D018808:Transcription Factor AP-1 / Q000037:antagonists & inhibitors / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014407:Tumor Cells, Cultured
D016328:NF-kappa B; D018808:Transcription Factor AP-1; D010770:Phosphotransferases; D001241:Aspirin; D012980:Sodium Salicylate